FindTrial
Sign In

Research on pathogen detection technology of central nervous system infection based on nanopore sequencing

Research on pathogen detection technology of central nervous system infection based on nanopore sequencing

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098192
Enrollment
Unknown
Registered
2025-03-04
Start date
2024-06-01
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central nervous system infection

Interventions

Case group:None
Control group:None

Sponsors

The Second Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Our hospital files patients with confirmed or suspected central nervous system infection; 2.Blood and cerebrospinal fluid should be collected before antimicrobial therapy or immunotherapy. 3.Have a pathogenic, serological or pathological examination report; 4.Age greater than 0 years old.

Exclusion criteria

Exclusion criteria: 1.Cerebrospinal fluid volume < 1ml, with blood cerebrospinal fluid; 2.Incomplete clinical data. 3.Over the age of 60.

Design outcomes

Primary

MeasureTime frame
Pathogen infection;—

Secondary

MeasureTime frame
Indicators of no infection;—

Countries

China

Contacts

Public ContactXiaoqun Zheng

The Second Affiliated Hospital of Wenzhou Medical University

jszhengxq@163.com+86 13906653839

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026